Sanglif

Sanglif Mechanism of Action

canagliflozin

Manufacturer:

Distributor:

Marketer:

San Lwin Trading

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Action

Canagliflozin is an inhibitor of subtype-2 sodium-glucose co-transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter reduces the reabsorption of glucose from renal tubules, leading to more excretion of glucose in urine.

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in

Sanglif Mechanism of Action

canagliflozin

Manufacturer:

Healthcare Pharma

Distributor:

San Lwin Trading

Marketer:

San Lwin Trading